Opioid Resource Center
From the Editor
Medication treatment of opioid use disorder in primary care practice: Opportunities and limitations
Restrictions on prescribing buprenorphine (BUP) for opioid use disorder (OUD) have been rescinded, increasing the opportunity for primary care...
Latest News
Opioid overdose is an important cause of postpartum death
Ob.gyns. have an opportunity to screen patients to identify those at high risk for opioid use disorder or opioid overdose, and a new law eases...
Feature
Physician pleads guilty to 52 counts in opioid scheme
The neuromuscular medicine specialist also admitted to ignoring patient requests to lower dosages and signs that patients were selling prescribed...
Clinical Review
Incorporating medication abortion into your ObGyn practice: Why and how
Latest News
Buprenorphine linked with lower risk for neonatal harms than methadone
The risk of adverse maternal outcomes was similar between the two treatments, according to a large study.
Latest News
Study: No more autopilot opioids after cesarean delivery
Sending patients home with smaller prescriptions led to dramatic drops in use of the drugs.
Latest News
Postpartum HCV treatment rare in infected mothers with opioid use disorder
While HCV screening and diagnosis rates varied across states, postpartum follow-up rates were universally low.
Latest News
ADHD link to prenatal opioid exposure shifts with other substances
Children’s risk profile for ADHD shifted based on which substances and substance combinations they were exposed to during pregnancy.
Latest News
Study questions reliability of maternal drug testing
“Cannabis and methadone were the significant factors leading to discordance with positive newborn meconium, which may reflect prior use earlier in...
Latest News
Opioid exposure in early pregnancy linked to congenital anomalies
While the absolute risk of congenital anomalies was low, these findings add to an increasing body of evidence suggesting that prenatal exposure to...
From the Journals
Opioid prescribing laws having an impact
The number of days an opioid was prescribed for each Medicare beneficiary decreased by 11.6 days in 2018 in states that imposed duration limits....